secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001493152-24-015220
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi amends $1.5M convertible note to allow payoff via registered offering participation
--------------------------------------------------------------------------------

- On April 14, 2024, amended a $1.5M convertible note issued to settle an unasserted claim.
- If holder participates in a registered public offering on same terms as others, proceeds from its sale will repay the note.
- Amendment incorporated by reference to Exhibit 10.51 of Form S-1 (No. 333-276741) filed April 15, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224015220/0001493152-24-015220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000149315224015220/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer